To meet our responsibilities and obligations as required by current legislation, Leriva has developed a pharmacovigilance system to monitor the safety of the medicines we market. Regardless of whether you are a health care professional or patient, by reporting a suspected adverse event, you actively contribute to the ongoing monitoring of the safety and quality of our medicinal products.
Ιf you wish to report a suspected adverse event related to our medicinal products, please contact us:
By phone: 210 61 99 886 – press 5 (24/7 availability)
By e-mail: firstname.lastname@example.org
All information collected during the reporting of an adverse reaction is confidential and anonymized, regarding both the reporter and the patient.